Metabolic Profile and Body Composition in Adult Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
The DOI matches its Crossref record; 31 of the 34 references it cites were found in a registry or an index.
Abstract
CONTEXT: The chronic, often supraphysiological glucocorticoid doses used in congenital adrenal hyperplasia (CAH) might increase morbidity in cardiovascular disease and diabetes. OBJECTIVE: Our aim was to assess risk factors for cardiovascular disease and diabetes in CAH women. SUBJECTS, METHODS, AND DESIGN: We compared 61 women, 18-63 yr, with CAH due to 21-hydroxylase deficiency with 61 age- and sex- matched controls. Twenty-seven were younger than 30 yr, and 34 were 30 yr or older. Anthropometry, fat and lean mass measured by dual-energy x-ray absorptiometry, serum lipids, insulin, and adrenocortical steroids were studied. MAIN OUTCOME MEASURE: Body composition and cardiovascular risk factors were the main outcome measures. RESULTS: Younger patients and controls had similar waist to hip ratio, lean and fat mass, and insulin. Older patients had higher waist to hip ratio, lean mass, and insulin than controls. Fat mass was similar to controls but higher than in younger patients. Lipid profiles were slightly more favorable in older patients than controls. Gestational diabetes was more common in patients (21% of pregnancies vs. 0, P < 0.026). Few older patients had hypertension, cardiovascular disease, or diabetes. Despite moderate glucocorticoid doses, most patients had suppressed androgens. CONCLUSIONS: No clear evidence of unfavorable cardiovascular risk factors were found. Increased fat mass and higher insulin levels were, however, found in patients older than 30 yr. High frequency of gestational diabetes is a risk marker for future diabetes. Lifelong follow-up, lifestyle modifications, and attempts to adjust and reduce the glucocorticoid doses seem important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Women with CAH are often overweight (202, 203, 260), but patients with CAH .30years of age had similar fat mass to age-matched controls.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [260]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The prevalence of overweight and obesity are greater in adults with CAH in the UK (360) and Sweden (671) but similar to the general population in the US (217) and France (626,672).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [672]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Women with CAH may be at increased risk for gestational diabetes (257, 260).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [260]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Mazess, R., Barden, H., Bisek, J., & Hanson, J. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.6.1106 · Cited by 1,476
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
KANNEL, W. B., CASTELLI, W. P., & GORDON, T. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-1-85 · Cited by 1,311
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Congenital Adrenal Hyperplasia: Is there an Effect on Penile Growth?
Levy, J. B., & Husmann, D. A. (1996) · The Journal of Urology · doi:10.1097/00005392-199608001-00060 · Cited by 415
Wedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370
Sex steroids and insulin resistance
LIVINGSTONE, C., & COLLISON, M. (2002) · Clinical Science · doi:10.1042/cs1020151 · Cited by 309
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“Longterm observational studies have been somewhat informative (227, 228, 230, 231).”
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
“also described increased fat mass and increased insulin levels inpatientsover30yr (13).”
BackgroundCongenital adrenal hyperplasia due to 21-hydroxylase deficiency
Merke, D. P., & Auchus, R. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1909786 · Cited by 341
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Frisén, L., Nordenström, A., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., Möller, A., & Nordenskjöld, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0636 · Cited by 276
Self-citationHagenfeldt, K., Janson, P. O., Holmdahl, G., Falhammar, H., Filipsson, H., Frisen, L., Thoren, M., & Nordenskjold, A. (2008) · Human Reproduction · doi:10.1093/humrep/den118 · Cited by 205
“She discontinued metformin in early pregnancy and developed mild gestational diabetes during the last part of the pregnancy and was treated with insulin (Falhammar et al., 2007c).”
BackgroundMethodNordenskjöld, A., Holmdahl, G., Frisén, L., Falhammar, H., Filipsson, H., Thorén, M., Janson, P. O., & Hagenfeldt, K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0556 · Cited by 205
“Age of onset and initial symptom varied with the severity of the mutation as previously described (16).”
BackgroundMethodSelf-citationFalhammar, H., Frisén, L., Hirschberg, A. L., Norrby, C., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2093 · Cited by 204
Self-citationIncreased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Falhammar, H., Frisén, L., Norrby, C., Hirschberg, A. L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2957 · Cited by 196
Self-citationCongenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 184
Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.002 · Cited by 177
Falhammar, H., Nyström, H. F., Ekström, U., Granberg, S., Wedell, A., & Thorén, M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0828 · Cited by 170
Self-citationMallappa, A., Sinaii, N., Kumar, P., Whitaker, M. J., Daley, L.-A., Digweed, D., Eckland, D. J. A., Van Ryzin, C., Nieman, L. K., Arlt, W., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3809 · Cited by 167
“0) CAH phenotype Salt wasting 12 (75) Simple virilizing 4 (25) Age, y 28.”
BackgroundNordenström, A., Frisén, L., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., & Nordenskjöld, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2639 · Cited by 161
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Self-citationFractures and bone mineral density in adult women with 21-hydroxylase deficiency
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0744 · Cited by 151
“Our patients were treated with supraphysiological glucocorticoid doses as the androgens were markedly suppressed (6).”
BackgroundSelf-citationCongenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 161
Corbould, A. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.872 · Cited by 144
“Affected adult women are hyperinsulinemic and are at increased risk of developing gestational diabetes mellitus [71].”
BackgroundClinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
Bulsari, K., & Falhammar, H. (2016) · Endocrine · doi:10.1007/s12020-016-1189-x · Cited by 149
“gestational and type 2 diabetes has been noted [2, 69, 80, 100].”
BackgroundManagement of adolescents with congenital adrenal hyperplasia
Merke, D. P., & Poppas, D. P. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70138-4 · Cited by 134
Engberg, H., Butwicka, A., Nordenström, A., Hirschberg, A. L., Falhammar, H., Lichtenstein, P., Nordenskjöld, A., Frisén, L., & Landén, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.06.017 · Cited by 132
“Patientswith CAHmay have elevated ACTH levels especially before the morning glucocorticoid medication or decreased levels due to over-replacement of glucocorticoids (Falhammar et al., 2007) Moreover, substance misuse is believed to be multifactorial, depending on genetic factors, cultural factors, coping styles, and p…”
BackgroundSelf-citationFalhammar, H., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0656-0 · Cited by 127
Self-citationTamhane, S., Rodriguez-Gutierrez, R., Iqbal, A. M., Prokop, L. J., Bancos, I., Speiser, P. W., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01862 · Cited by 123
Approach to the patient: the adult with congenital adrenal hyperplasia
Auchus, R. J., & Arlt, W. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1440 · Cited by 121
“Mineralocorticoid replacement In contrast to the salt-wasting tendency of all children withclassic21OHD,adolescents (8)andadults (6)withclassic 21OHD are prone to developing hypertension.”
BackgroundHealth Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Reisch, N., Arlt, W., & Krone, N. (2011) · Hormone Research in Paediatrics · doi:10.1159/000327794 · Cited by 106
“but no change in body fat distribution has been found [”
BackgroundClinical outcomes in the management of congenital adrenal hyperplasia
Falhammar, H., & Thorén, M. (2012) · Endocrine · doi:10.1007/s12020-011-9591-x · Cited by 106
Self-citationFalhammar, H., Filipsson Nyström, H., Wedell, A., & Thorén, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0877 · Cited by 103
Self-citationTreatment and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Walker, B. R., Arlt, W., & Ross, R. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.239 · Cited by 102
Nonclassic Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/625105 · Cited by 101
“Available studies regarding insulin sensitivity have provided inconsistent results and generally involve women with classical forms of CAH [77, 78].”
ResultFalhammar, H., Butwicka, A., Landén, M., Lichtenstein, P., Nordenskjöld, A., Nordenström, A., & Frisén, L. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3707 · Cited by 98
Self-citationRiepe, F. G., & Sippell, W. G. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9053-1 · Cited by 108
“A recent study revealed that apart from increased fat mass and higher insulin levels no clear evidence for unfavourable cardiovascular risk factors can be found in CAH patients older than 30 years of age [120].”
BackgroundMooij, C. F., Kroese, J. M., Claahsen‐van der Grinten, H. L., Tack, C. J., & Hermus, A. R. M. M. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03690.x · Cited by 92
Nermoen, I., Husebye, E. S., Svartberg, J., & Løvås, K. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0284 · Cited by 89
Whittle, E., & Falhammar, H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00136 · Cited by 87
“The frequency of particular glucocorticoid regimens varies between cohorts [3, 8, 36].”
BackgroundSelf-citationGiordano, R., Marzotti, S., Balbo, M., Romagnoli, S., Marinazzo, E., Berardelli, R., Migliaretti, G., Benso, A., Falorni, A., Ghigo, E., et al. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345773 · Cited by 84
Adrenal crises: perspectives and research directions
Rushworth, R. L., Torpy, D. J., & Falhammar, H. (2016) · Endocrine · doi:10.1007/s12020-016-1204-2 · Cited by 100
Al Alawi, A. M., Nordenström, A., & Falhammar, H. (2019) · Endocrine · doi:10.1007/s12020-018-01835-3 · Cited by 77
Self-citationHealth status in 1040 adults with disorders of sex development (DSD): a European multicenter study
Falhammar, H., Claahsen-van der Grinten, H., Reisch, N., Slowikowska-Hilczer, J., Nordenström, A., Roehle, R., Bouvattier, C., Kreukels, B. P. C., Köhler, B., & _, _. (2018) · Endocrine Connections · doi:10.1530/ec-18-0031 · Cited by 76
Subbarayan, A., Dattani, M. T., Peters, C. J., & Hindmarsh, P. C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12265 · Cited by 73
Long-Term Outcome of Disorders of Sex Development
Warne, G. L. (2008) · Sexual Development · doi:10.1159/000152043 · Cited by 78
“…in control groups [Kuhnle et al., 1993, 1995; May et al., 1996], have greater degrees of pain and discomfort associated with penetrative intercourse [Warne et al., 2005a], are less fertile [Hagenfeldt et al., 2008], and have an increased risk of gestational diabetes [Falhammar et al., 2007].”
BackgroundWilliams, R. M., Deeb, A., Ong, K. K., Bich, W., Murgatroyd, P. R., Hughes, I. A., & Acerini, C. L. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03587.x · Cited by 69
Marra, A. M., Improda, N., Capalbo, D., Salzano, A., Arcopinto, M., De Paulis, A., Alessio, M., Lenzi, A., Isidori, A. M., Cittadini, A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1805 · Cited by 67
“Blood pressure control in CAH has been investigated by several independent groups, with some studies reporting normal resting (21, 30, 31) and 24h BP profile (32) and others reporting either diurnal (33) or both diurnal and nocturnal SBP significantly elevated (34) and positively related to increased BMI.”
BackgroundBody image and self-esteem in disorders of sex development: A European multicenter study.
van de Grift, T. C., Cohen-Kettenis, P. T., de Vries, A. L. C., & Kreukels, B. P. C. (2018) · Health Psychology · doi:10.1037/hea0000600 · Cited by 66
“Prior research on body composition of women with CAH indicated increased waist–hip ratios, suggesting a less gynoid body shape (Falhammar et al., 2007).”
BackgroundHan, T. S., Conway, G. S., Willis, D. S., Krone, N., Rees, D. A., Stimson, R. H., Arlt, W., Walker, B. R., Ross, R. J., & (CaHASE), T. U. K. C. A. H. A. S. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1486 · Cited by 65
Management considerations for the adult with congenital adrenal hyperplasia
Auchus, R. J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.039 · Cited by 65
46,XX DSD: the masculinised female
Auchus, R. J., & Chang, A. Y. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.11.001 · Cited by 67
Steroid 21 Hydroxylase Deficiency Congenital Adrenal Hyperplasia
Nimkarn, S., Lin‐Su, K., & New, M. I. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.07.012 · Cited by 67
Adrenal Crises in Children: Perspectives and Research Directions
Rushworth, R. L., Torpy, D. J., Stratakis, C. A., & Falhammar, H. (2018) · Hormone Research in Paediatrics · doi:10.1159/000481660 · Cited by 60
Self-citationBilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
MacKay, D., Nordenström, A., & Falhammar, H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00217 · Cited by 59
“Sex Female 35 (73) 22 (85) 13 (59) Male 12 (25) 4 (15) 8 (36) Not specified 1 (2) 0 (0) 1 (5) Mean age, y 20 6 13 10 (5) 32 (10) Diagnosis 11OHD 7 (15) 3 (12) 4 (18) 21OHD 41 (85) 23 (88) 18 (82) SW 20 (42) 11 (42) 10 (45) SV 5 (10) 2 (8) 3 (14) Unspecified 16 (33) 10 (38) 5 (23) Indication for adrenalectomy Hyperandr…”
BackgroundSelf-citationRangaswamaiah, S., Gangathimmaiah, V., Nordenstrom, A., & Falhammar, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00493 · Cited by 59
“In our systematic review, two studies (36, 42) reported BMD corrected for height, two studies reported BMD corrected for BMI (35, 43) and the rest reported uncorrected BMD.”
BackgroundInfluentialSelf-citationAdult Consequences of Congenital Adrenal Hyperplasia
Arlt, W., & Krone, N. (2007) · Hormone Research in Paediatrics · doi:10.1159/000110615 · Cited by 58
“A study addressing the metabolic profile and body composition of 61 female CAH patients in Sweden did not show clear evidence of cardiovascular risk factors. However, increased fat mass and higher insulin levels were found in patients older than 30 years. Furthermore, a significantly higher rate of gestational diabete…”
BackgroundWebb, E. A., & Krone, N. P. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.04.002 · Cited by 72
“Exposure to high concentrations of glucocorticoids suppresses growth, increases blood pressure and can cause osteoporosis and iatrogenic Cushing’s syndrome (34,83,84,91,98).”
BackgroundBachelot, A., Grouthier, V., Courtillot, C., Dulon, J., & Touraine, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0888 · Cited by 57
Congenital Adrenal Hyperplasia: clinical symptoms and diagnostic methods
Podgórski, R., Aebisher, D., Stompor, M., Podgórska, D., & Mazur, A. (2018) · Acta Biochimica Polonica · doi:10.18388/abp.2017_2343 · Cited by 70
“Sometimes, unfortunately, this is not easy to achieve and higher doses are necessary in many cases resulting in overtreatment with an increased risk of longterm side effects (Falhammar et al., 2007; Falhammar et al., 2013).”
BackgroundPaizoni, L., Auer, M. K., Schmidt, H., Hübner, A., Bidlingmaier, M., & Reisch, N. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105540 · Cited by 53
Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia
Nimkarn, S., Lin-Su, K., & New, M. I. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.08.001 · Cited by 52
Bachelot, A., Golmard, J. L., Dulon, J., Dahmoune, N., Leban, M., Bouvattier, C., Cabrol, S., Leger, J., Polak, M., & Touraine, P. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0978 · Cited by 46
Cardiovascular risk factors and events in women with androgen excess
Μacut, D., Antić, I. B., & Bjekić-Macut, J. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0215-1 · Cited by 47
Daae, E., Feragen, K. B., Nermoen, I., & Falhammar, H. (2018) · Endocrine · doi:10.1007/s12020-018-1723-0 · Cited by 45
“girl with SW will die of a salt-losing crisis within the first few weeks if not diagnosed and properly treated [3, 9].”
BackgroundSelf-citationAmr, N. H., Ahmed, A. Y., & Ibrahim, Y. A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0148-8 · Cited by 44
“Obesity has been previously reported in both pediatric and adult patients with CAH [22, 26, 27].”
BackgroundStewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Voice characteristics in women with congenital adrenal hyperplasia due to 21‐hydroxylase deficiency
Nygren, U., Södersten, M., Falhammar, H., Thorén, M., Hagenfeldt, K., & Nordenskjöld, A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03347.x · Cited by 43
Nermoen, I., Brønstad, I., Fougner, K. J., Svartberg, J., Øksnes, M., Husebye, E. S., & Løvås, K. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0196 · Cited by 43
Falhammar, H., Frisén, L., Hirschberg, A. L., Nordenskjöld, A., Almqvist, C., & Nordenström, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab712 · Cited by 42
Mooij, C. F., Kroese, J. M., Sweep, F. C. G. J., Hermus, A. R. M. M., & Tack, C. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024204 · Cited by 42
“Our finding of an elevated 24-hour blood pressure profile in adult CAH patients was not reported in earlier studies in adult CAH patients.[9,10] However, studies in young adult and pediatric CAH patients did show a tendency towards hypertension.”
BackgroundResultLong-Term Outcomes of Congenital Adrenal Hyperplasia
Nordenström, A., Lajić, S., & Falhammar, H. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1528 · Cited by 50
“However, this could partly reflect an increase in lean mass in women with CAH due to high androgen exposure during life [23].”
InfluentialKim, M., & Merke, D. (2009) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1225259 · Cited by 41
“In adult females with CAH, women 30 years old had a higher standing DBP compared with that of younger patients.(19) Anecdotally, hypotensive crises are uncommon in adults, suggesting a tendency to higher blood pressure and less salt-wasting with age.”
ResultInfluentialQuality of life of patients with 46, XX and 46, XY disorders of sex development
Amaral, R. C., Inácio, M., Brito, V. N., Bachega, T. A. S. S., Domenice, S., Arnhold, I. J. P., Madureira, G., Gomes, L. G., Costa, E. M. F., & Mendonca, B. B. (2014) · Clinical Endocrinology · doi:10.1111/cen.12561 · Cited by 51
Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
Adriaansen, B. P. H., Schröder, M. A. M., Span, P. N., Sweep, F. C. G. J., van Herwaarden, A. E., & der Grinten, H. L. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1064024 · Cited by 51
Falhammar, H., Nyström, H. F., & Thorén, M. C. (2014) · Endocrine · doi:10.1007/s12020-013-0161-2 · Cited by 43
Infertility and Reproductive Function in Patients with Congenital Adrenal Hyperplasia
Lekarev, O., Lin-Su, K., & Vogiatzi, M. G. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.07.009 · Cited by 38
Moreira, R. P. P., Gomes, L. G., Mendonca, B. B., & Bachega, T. A. S. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044893 · Cited by 38
“There is evidence of the increased prevalence of overweight/obesity in CAH patients compared to the normal population [6,7,23], and there is debate on whether long-term GC exposure or higher GC doses might be”
BackgroundZimmermann, A., Grigorescu-Sido, P., AlKhzouz, C., Patberg, K., Bucerzan, S., Schulze, E., Zimmermann, T., Rossmann, H., Geiss, H.-C., Lackner, K. J., et al. (2010) · Hormone Research in Paediatrics · doi:10.1159/000313368 · Cited by 38
“have been reported in children and adolescents with 21HD, with potential long-term complications in later life. Falhammar et al. [”
BackgroundWasniewska, M. G., Balsamo, A., Valenzise, M., Manganaro, A., Faggioli, G., Bombaci, S., Conti, V., Ferri, M., Aversa, T., Cicognani, A., et al. (2013) · PubMed · doi:10.3275/8194 · Cited by 37
Classical Forms of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Adults
Bachelot, A., Chakthoura, Z., Rouxel, A., Dulon, J., & Touraine, P. (2008) · Hormone Research in Paediatrics · doi:10.1159/000113020 · Cited by 37
“Another recent study showed higher insulin levels in the CAH women above 30 years compared with controls. Moreover, they reported a high frequency of gestational diabetes among these patients, potentially indicating a higher risk of developing diabetes in the near future [”
BackgroundGuidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
Ishii, T., Anzo, M., Adachi, M., Onigata, K., Kusuda, S., Nagasaki, K., Harada, S., Horikawa, R., Minagawa, M., Minamitani, K., et al. (2015) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.24.77 · Cited by 44
Reisch, N. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0820-2085 · Cited by 36
“Studies investigating blood pressure show conflicting results with either normal [18, 21, 30, 31] or elevated blood pressure [32].”
BackgroundEngberg, H., Möller, A. R., Hagenfeldt, K., Nordenskjöld, A., & Frisén, L. (2016) · Clinical Endocrinology · doi:10.1111/cen.13054 · Cited by 40
FALHAMMAR, H., FILIPSSON, H., HOLMDAHL, G., JANSON, P.-O., NORDENSKJÖLD, A., HAGENFELDT, K., & THORÉN, M. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-312 · Cited by 35
Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency
Ariyawatkul, K., Tepmongkol, S., Aroonparkmongkol, S., & Sahakitrungruang, T. (2017) · European Journal of Pediatrics · doi:10.1007/s00431-017-2875-2 · Cited by 36
Mooij, C. F., van Herwaarden, A. E., Sweep, F. C. G. J., Roeleveld, N., de Korte, C. L., Kapusta, L., & Claahsen-van der Grinten, H. L. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0068 · Cited by 33
“[6, 43] found normal fat mass with the DXA scan in young adult CAH patients compared to controls.”
BackgroundLi, L., Bensing, S., & Falhammar, H. (2021) · Endocrine · doi:10.1007/s12020-021-02723-z · Cited by 37
Sarafoglou, K., Merke, D. P., Reisch, N., der Grinten, H. L. C., Falhammar, H., & Auchus, R. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad134 · Cited by 35
Congenital adrenal hyperplasia in adults
Auchus, R. J. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833961d7 · Cited by 30
Gomes, L. G., Mendonca, B. B., & Bachega, T. A. S. S. (2020) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000545 · Cited by 27
“Studies comprising either CAH children and young adults [24] or women [10], under different glucocorticoid regimens, identified comparable lipid profiles in relation to controls.”
BackgroundMoreira, R. P. P., Villares, S. M., Madureira, G., Mendonca, B. B., & Bachega, T. A. S. S. (2013) · Hormone Research in Paediatrics · doi:10.1159/000353762 · Cited by 33
Kocova, M., Anastasovska, V., & Falhammar, H. (2020) · Endocrine · doi:10.1007/s12020-020-02323-3 · Cited by 24
Self-citationCardiometabolic Aspects of Congenital Adrenal Hyperplasia
Krysiak, R. G., der Grinten, H. L. C., Reisch, N., Touraine, P. A., & Falhammar, H. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae026 · Cited by 26
Substitution therapy in adult patients with congenital adrenal hyperplasia
Reisch, N. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.11.002 · Cited by 24
Falhammar, H., Frisén, L., Hirschberg, A. L., Nordenskjöld, A., Almqvist, C., & Nordenström, A. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00122 · Cited by 23
“Before the introduction of neonatal screening, especially boys but also some girls with SV 21OHD were identified later during childhood and thus were not treated with glucocorticoids from the neonatal period [30, 31].”
BackgroundSahlander, F., Patrova, J., Mannheimer, B., Lindh, J. D., & Falhammar, H. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01933-0 · Cited by 24
“Patients with suspected SW CAH where the exact age of diagnosis was not available, the age was set at 0 years, in line with previous studies [4, 5].”
BackgroundResultLong-term health issues related to disorders or differences in sex development/intersex
Beale, J. M. A., & Creighton, S. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.10.003 · Cited by 25
Russian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 30
Nygren, U., Nyström, H. F., Falhammar, H., Hagenfeldt, K., Nordenskjöld, A., & Södersten, M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12226 · Cited by 21
Endocrine disease in pregnancy
Frise, C., & Williamson, C. (2013) · Clinical Medicine · doi:10.7861/clinmedicine.13-2-176 · Cited by 23
Stewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 35
Insulin Resistance in Congenital Adrenal Hyperplasia is Compensated for by Reduced Insulin Clearance
de Oliveira, D. M., Tura, A., Vasques, A. C. J., Camilo, D. F., Lima, M. M. D. O., de Lemos‐Marini, S. H. V., Gonçalves, E. M., Guerra‐Júnior, G., & Geloneze, B. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab010 · Cited by 18
Metadata
- Authors
- Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M.
- Affiliations
- Karolinska University Hospital (SE)
- Department of Endocrinology (H.Fi.), Sahlgrenska University Hospital and Sahlgrenska Academy, SE-413 45 Gothenburg, Sweden
- Drottning Silvias barn- och ungdomssjukhus (SE)
- Sahlgrenska University Hospital (SE)
- Department of Molecular Medicine and Surgery (H.Fa., A.N., M.T.), Karolinska University Hospital and Karolinska Institute, SE-171 76 Stockholm, Sweden
- Department of Endocrinology, Metabolism, and Diabetes (H.Fa., M.T.), Karolinska University Hospital and Karolinska Institute, SE-171 76 Stockholm, Sweden
- Corresponding author
- Falhammar, Henrik
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-01-01
- Volume
- 92
- Issue
- 1
- Pages
- 110-116
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2124458165
- Cited by
- 167
- References
- 34
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 6 · 2022: 9 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 11 · 2017: 4 · 2016: 7 · 2015: 11 · 2014: 12 · 2013: 13 · 2012: 11
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Göteborgs Läkaresällskap
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, body composition, fat mass, lean body mass, waist-to-hip ratio, insulin, cardiovascular risk factors, diabetes risk, gestational diabetes mellitus, glucocorticoid dose, androgen deprivation therapy, serum lipids, women
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adult, Blood Pressure, Body Composition, Body Weight, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Middle Aged, Steroid 21-Hydroxylase, Body Mass Index, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.